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Low Na1 diet inhibits Na1 and water transport response to
vasopressin in rat cortical collecting duct
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Low Na1 diet inhibits Na1 and water transport response to vasopressin
in rat cortical collecting duct.
Background. We previously demonstrated that vasopressin (AVP) pro-
duces a sustained increase in Na1 reabsorption by the isolated perfused
cortical collecting duct (CCD) from rats on a normal diet, and that this
effect is synergistic with that of pharmacological doses of deoxycortico-
sterone (DOC) or physiological levels of aldosterone. The present exper-
iments examined the effect of AVP under the more physiological circum-
stances when plasma aldosterone was elevated by prior volume depletion.
Methods. Rats were volume depleted by a single dose of furosemide
followed by a low-salt diet (0.3% NaCl) for four to nine days. Some of
these rats were also implanted with a pellet containing 2.5 mg DOC. Rats
in a third group were not injected with furosemide but were implanted
with the DOC pellet and maintained on a standard (;1% NaCl) diet.
CCD were perfused and the lumen-to-bath Na1 flux (JNa), transepithelial
voltage (VT), and osmotic water permeability (Pf) were measured in the
presence and absence of 200 pM AVP.
Results. Although Na1 depletion by a single injection of furosemide and
the low salt diet elevated plasma aldosterone and VT, JNa remained low
and there was a decreased response to AVP in comparison with DOC-
treated rats on a standard diet. In CCD from rats on the low salt-diet with
DOC, JNa was less than observed in CCD from DOC-treated rats on a
standard diet. AVP-dependent Pf in CCD from rats on the low-salt diet,
with or without DOC treatment, was also markedly lower.
Conclusions. We interpret the results to demonstrate that maximal rates
of Na1 reabsorption in the CCD depend not only on the synergistic
stimulatory effects of aldosterone and AVP, but also require normal to
high rates of salt delivery in vivo for the effects of the hormones on Na1
transport to be maximized in vitro.
Our previous experiments with the rat cortical collecting
duct (CCD) have shown that arginine vasopressin (AVP)
produces a marked stimulation of Na1 reabsorption that is
synergistic to the effect of pharmacological concentrations
of the mineralocorticoid deoxycorticosterone (DOC) [1, 2].
We have subsequently demonstrated that this synergism
also occurs when the mineralocorticoid used is aldosterone
at concentrations corresponding to what is observed in vivo
with only moderate salt depletion [3]. However, we ob-
served that the AVP concentration required to achieve a
maximal synergistic effect was greater with the aldosterone
treatment compared to the DOC treatment, although in
both instances significant stimulation of Na1 transport was
produced at physiologically relevant concentrations of AVP
(5 to 40 pM).
The effects of both aldosterone and DOC on the trans-
port capacity of the rat CCD may relate to the direct effect
of the mineralocorticoid and/or to changes in the delivery
of Na1 to the distal nephron. As shown in the classic study
of Schwartz and Burg [4], Na1 and K1 transport in the
rabbit CCD measured in vitro are altered by in vivo dietary
manipulation. For example, when plasma aldosterone was
reduced to zero by a high-Na1/low-K1 diet, Na1 reabsorp-
tion and K1 secretion were reduced to 50% of control
levels. When plasma aldosterone was increased 18-fold by a
low-salt diet and furosemide treatment, Na1 reabsorption
and K1 secretion increased about two-fold [4]. These and
other observations showed that the rate of Na1 and K1
transport in vitro was closely correlated with the plasma
aldosterone concentration in vivo despite the fact that no
mineralocorticoid was present in the in vitro solutions in
which the CCD were studied [4].
In other studies, it has been shown that the rate of Na1
delivery and/or the intracellular Na1 concentration may
also alter transport rates in the distal tubule and collecting
duct independent of changes in aldosterone. Stanton and
Kaissling [5, 6] demonstrated that increasing Na1 delivery
to the distal nephron by furosemide and a high-salt intake
increased the volume and basolateral membrane surface
area of DCT cells, connecting tubule cells, and principal
cells of the collecting ducts. In these and other studies [7]
the morphologicial changes were accompanied by an in-
creased capacity of the distal tubule to reabsorb Na1 and
secrete K1. These changes occurred despite the fact that
the plasma aldosterone concentration was maintained con-
stant by prior adrenalectomy and corticoid replacement by
osmotic minipump. Similarly, increased in vivo Na1 deliv-
ery to the distal nephron increased Na1 transport rates
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measured in the isolated perfused rabbit CCD [8, 9]. The
interpretation of these studies is that increased Na1 trans-
port in response to increased Na1 delivery to the distal
nephron segments results in a “hypertrophy” of the cells
and the transporters involved [6, 7, 10].
Examining our previous studies demonstrating the syn-
ergism between physiologic aldosterone and AVP concen-
trations [3], there could be two reasons for the increased
transport capacity of the CCD. Because the rats in these
studies were maintained on a standard 1% NaCl diet, it
would be expected that distal Na1 delivery would be
increased due to the mineralocorticoid escape phenome-
non. Thus, not only might aldosterone have increased the
transport capacity of the CCD through a direct action on
the principal cells, but alternatively or in addition, in-
creased Na1 delivery to the CCD might have produced the
increase. Thus, the situation in our previous experiments,
that is, increased aldosterone with a normal Na1 intake and
no extrarenal Na1 loss, was not truly physiological.
For this reason we undertook experiments to produce a
more typical setting in which the physiological interplay of
mineralocorticoids and AVP could be examined. We chose
to study CCD from rats that had been treated with a single
dose of furosemide and then maintained on a low-salt diet
(0.3%) as a model in which plasma aldosterone concentra-
tions would be moderately but not severely elevated due to
mild volume depletion. The results reinforced the impor-
tance of salt delivery in the response to mineralocorticoid,
and also indicated the presence of more complex effects on
both the osmotic water permeability and Na1 transport
response to AVP.
METHODS
Cortical collecting ducts were dissected from outbred
Sprague-Dawley rats (Harlan Sprague Dawley, Indianapo-
lis, IN, USA). When received, the rats weighed 40 to 50 g.
Two days after receipt the rats were treated according to
one of three protocols:
(1) Low-salt group. Administration of a single 2 mg dose
of furosemide intramuscularly, followed by maintenance on
a diet containing nominally 0.3% NaCl (Diet #100077 from
Dyets, Inc., Bethlehem, PA, USA; based on AIN-76 pel-
leted diet; measured in our laboratory as containing 0.37%
NaCl).
(2) DOC 1 low salt group. At the same time the rats were
given furosemide as in the previous protocol, they were also
anesthetized by brief exposure to CO2, and a 2.5 mg pellet
of deoxycorticosterone (DOC; Innovative Research of
America, Toledo, OH, USA) was implanted subcutane-
ously in the interscapular region with a trochar designed for
this purpose. These rats were then maintained on the 0.3%
NaCl diet for four to nine days before use.
(3) DOC 1 standard diet group. Implantation of a 2.5 mg
DOC pellet as above, without furosemide, was followed by
maintenance on a standard diet of pelleted rat chow
(Prolab RMH100; Agway Inc., Syracuse, NY, USA; con-
taining 0.99% NaCl as measured in our laboratory) and tap
water, both ad libitum.
Rats in all groups weighed 80 to 110 g at the time of
tubule dissection.
In rats maintained on the low-salt protocol (without
DOC), serum samples were collected at the time of the
experiment and were analyzed for aldosterone by radioim-
munoassay using the Coat-A-Count kit (Diagnostic Prod-
ucts Corp., Los Angeles, CA, USA) according to the
accompanying directions. The average aldosterone concen-
tration was 0.73 6 0.12 nM (26.4 6 4.4 ng/dl; N 5 17). This
is significantly higher than aldosterone levels typically
measured in control animals of approximately the same size
and on the same diet, that is, 0.11 to 0.19 nM (4 to 7 ng/dl)
[11], but much less than values observed with severe
chronic sodium depletion, which have been reported to be
as high as 13.9 nM (500 ng/dl) with a completely salt-free
paste diet [11–13]. Thus, the plasma aldosterone levels
could be regarded as moderately elevated in comparison
with controls on a standard diet.
The techniques used to dissect and perfuse CCD from
rat nephrons have been previously described in detail [1, 2,
14]. In all experiments, the perfusate solution composition
and pH approximated that of fluid in the early distal tubule
[15], and contained (in mM): 88 NaCl, 5 KCl, 2 sodium
phosphate (final pH 6.6), 1.5 CaCl2, 0.5 MgCl2, and 50
urea. The solution was equilibrated with 95% O2/5% CO2
at 38°C, and the measured osmolality was 200 to 230
mOsm/kg H2O. The bathing solution approximated an
ultrafiltrate of rat serum and contained (in mM): 122 NaCl,
25 NaHCO3, 5 KCl, 5 sodium acetate, 2 sodium phosphate
(final pH 7.4), 1.5 CaCl2, 0.5 MgCl2, 8 glucose, 4 L-alanine,
and 6 urea. The measured osmolality averaged 314.7 6 5.7
(standard deviation; SD) mOsm/kg H2O, and the pH was
adjusted to 7.40 when equilibrated with a 95%/5% mixture
of O2 and CO2 at 38°C.
The experiments were carried out at 38°C, and were
designed so that measurements of JNa, Pf, and VT could be
performed in the same experiment. The volume marker,
[methoxy-3H]-inulin, was added to the perfusate at ;50
mCi/ml to determine the perfusion rate, and the leakage of
perfusate was measured from the rate of appearance of 3H
in the bathing solution. Only experiments with 3H leak
rates less than 1% of that perfused were included in the
reported data. The perfusion rate was 10 to 15 nl/min.
Measurement of Na1 and water transport parameters
The rate of volume absorption was calculated and nor-
malized by the tubule length as described previously [1, 14,
16]. The length of the tubule segment was measured at the
end of an experiment using an ocular micrometer. Pf was
calculated from the observed water flow and the measured
osmolalities of the initial perfusate solution and the bathing
solution [1, 14, 16].
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JNa was determined by adding ;50 mCi/ml
22Na1 to the
perfusate solution and measuring the rate of appearance of
22Na1 in the bathing solution, as described previously [1, 2,
14, 16]. In all experiments VT was measured continuously
between 0.9% NaCl-4% agarose bridges placed in the
perfusate and bathing solutions, and displayed on a strip
chart recorder. For convenience, VT values will be dis-
cussed in terms of their absolute value. Thus, for example,
a hyperpolarization of the usually lumen-negative VT is
referred to as an increase in VT.
Experimental protocols
After dissection in chilled bathing solution, CCD were
mounted between the perfusion and collection pipettes,
and the perfusion solution was changed to one containing
the 3H-methoxyinulin and 22Na1. The temperature was
raised from room temperature to 38°C over a 10 to 15
minute period. After a stable VT had been achieved,
samples of the collected bath and lumen perfusates were
taken at 10 minutes intervals.
The protocols were the same with each group of rats.
There was an initial control period in which no drugs were
added. Five or six 10-minute collections of the bathing and
perfusing solutions were made for determination of JNa and
Pf. AVP was then added at 200 pM to the bathing solution
and five collection periods followed. In the third period a
potential inhibitor of JNa and Pf was added to the bathing
solution or to the luminal perfusate, followed by five
collection periods. In some protocols there was a final
period of five collections in which the inhibitor was re-
moved and only AVP remained in the bathing solution. In
each period parameter values in the last three collections
were averaged to give a value for that period. Individual
experiment averages were in turn averaged to give a mean
value for the protocol.
Sources of biochemicals
Synthetic arginine vasopressin, hydrochlorothiazide
(HCTZ), L-(-)-epinephrine, yohimbine and ouabain were
obtained from Sigma Chemical Co. (St. Louis, MO, USA).
A stock solution of 200 mM AVP in water was prepared
weekly, and was added to the bathing solution to give a final
concentration of 200 pM. HCTZ was prepared directly in
the luminal perfusate solution at 100 mM. A fresh 1 mM
stock solution of epinephrine in water was made immedi-
ately before each experiment in which it was used. Aliquots
of a stock solution of 1 mM yohimbine in water were frozen
for use in individual experiments. Ouabain was frozen in
aliquots of a 20 mM stock solution in water. Benzamil was
a gift from Dr. T.R. Kleyman (Univ. of Pennsylvania); it
was prepared as a 1 mM stock solution in dimethylsulfoxide.
The isotopic tracers [methoxy-3H]-inulin and 22Na1 were
obtained from DuPont-New England Nuclear Products
(Boston, MA, USA).
Data analysis and statistics
Average parameter values were calculated for each
period in each experiment. These averages were then used
to compute an overall average parameter value (6 SE) for
all experiments in each protocol. Treatment effects among
experimental periods within the same protocol were tested
for significance (P , 0.05) by ANOVA (SuperANOVA
software; Abacus Concepts, Berkeley, CA, USA) with
experiments treated as blocks, using the Scheffe´ F-ratio
test. Comparisons between different groups of animals
were made by nonpaired t-test with significance at P , 0.05.
RESULTS
In our first series of experiments we examined the effects
of salt depletion on transport parameters in CCD from the
low-salt group of rats. In 15 experiments, JNa in the control
Fig. 1. Effect of diet and mineralocorticoid
treatment on lumen-to-bath of 22Na1 flux (JNa).
Cortical collecting ducts (CCD) from three
groups of rats were examined: (A) rats that had
been treated with furosemide and kept on a
low-salt diet (N 5 15), (B) rats that had been
treated with furosemide, implanted with a 2.5
mg deoxycorticosterone (DOC) pellet, and kept
on the low-salt diet (N 5 11), and (C) rats that
were implanted with a DOC pellet and were
kept on a standard diet (Std. Diet; N 5 7).
Results from individual experiments are shown
by the dashed lines, and the average for all
experiments in a group by the solid lines. See
text for statistical comparisons.
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period was 22.2 6 3.3 pmol z min21 z mm21 and rose sig-
nificantly (P , 0.001 by paired t-test) to 48.6 6 4.3 upon
addition of 200 pM AVP to the bathing solution (Fig. 1A).
Pf was not significantly different from zero in the control
period (23 6 34 mm/second) but rose significantly (P ,
0.001) to 418 6 56 mm/second after addition of 200 pM
AVP (Fig. 2A).
The 15 CCD examined in the low-salt group were divided
into three subgroups in which the effects of epinephrine,
ouabain, and HCTZ were examined as shown in Table 1.
Addition of either 100 nM epinephrine or 100 mM ouabain
to the bathing solution, which still contained AVP, signifi-
cantly inhibited JNa and VT; however, epinephrine inhibited
Pf whereas ouabain had no effect. The effects of epineph-
rine were reversed by 1 mM of the a2-adrenoceptor antag-
onist yohimbine. Ouabain removal reversed its effect on
VT. The reversibility of the ouabain effects on JNa and Pf
were not examined because the final period was only
maintained for five minutes, which was sufficient to dem-
onstrate the reversal of VT. Luminal HCTZ had no signif-
icant effect on Pf, JNa, or VT.
Because all parameter values in the low-salt group were
significantly less than had been anticipated from the in-
creased plasma aldosterone concentration, we examined
CCD from rats receiving furosemide and the low-salt diet,
but which were also implanted with a DOC pellet (Table 2;
Figs. 1B and 2B). JNa in the control period was 39.0 6 4.9
and rose significantly (P , 0.001) to 103.4 6 12.7 pmol z
min21 z mm21 upon the addition of AVP to the bathing
solution (Fig. 1B). Nonpaired t-tests revealed that JNa for
the DOC 1 low-salt group was higher in both the control
period (P 5 0.004) and in the AVP period (P , 0.001)
compared with the low-salt group. However, VT and Pf
values were not significantly different between the two
groups in either period. The further addition of 100 nM
epinephrine in the third period significantly inhibited all
three parameters, and the effect was reversed by 1 mM
yohimbine (Table 2).
CCD from rats treated with furosemide and low-salt,
either with or without DOC treatment, had lower Pf values
in the presence of AVP than observed in previous studies
with rats on a standard diet. To confirm this we conducted
a third set of experiments with CCD from rats in the DOC
1 standard diet group, which repeated previous protocols,
such as, [1–3, 17]. As shown in Figure 1C and Table 3, JNa
Fig. 2. Effect of diet and mineralocorticoid
treatment on osmotic water permeability (Pf).
Cortical collecting ducts (CCD) from three
groups of rats were examined: (A) rats that had
been treated with furosemide and kept on a
low-salt diet (N 5 15), (B) rats that had been
treated with furosemide, implanted with a 2.5
mg deoxycorticosterone (DOC) pellet, and kept
on the low-salt diet (N 5 11), and (C) rats that
were implanted with a DOC pellet and were
kept on a standard diet (Std. Diet; N 5 7).
Results from individual experiments are shown
by the dashed lines, and the average for all
experiments in a group by the solid lines. See
text for statistical comparisons.
Table 1. Osmotic water permeability (Pf), transepithelial voltage (VT),
and lumen-to-bath 22Na1 flux (JNa) in cortical colleting ducts (CCD)
from rats treated with furosemide and the low-salt diet
Experimental
period
Pf
mm/second
VT
mV
JNa
pmol z min21 z mm21
Control 13 6 23 21.7 6 0.5 21.7 6 3.4
AVP 312 6 64a 217.1 6 3.3a 48.3 6 3.6a
AVP & Epi 138 6 47ab 28.3 6 2.0ab 36.9 6 40.4ab
AVP, Epi & Yoh 326 6 55ab 213.1 6 2.7ab 49.3 6 3.1ab
Control 2131 6 15 23.4 6 1.6 33.5 6 7.7
AVP 467 6 9a 212.8 6 3.6a 69.0 6 6.8a
AVP & ouabain 491 6 52a 26.1 6 2.0b 31.0 6 11b
AVP — 212.4 6 4.2ab —
Control 54 6 79 24.9 6 2.0 17.0 6 5.5
AVP 515 6 126a 221.4 6 3.3a 36.3 6 4.0a
AVP & HCTZ 582 6 100a 222.6 6 3.8a 37.1 6 2.4a
All CCD were from rats that had been treated with furosemide and
maintained on a low salt diet as described in the Methods section. In the
first group of experiments (N 5 6), 100 nM epinephrine (Epi) was added
to the bathing solution in the third period, followed by the further addition
of 1 mM yohimbine (Yoh) to the bathing solution in the last period. In the
second group (N 5 4), 100 mM ouabain was added to the bathing solution
in the third period, and removed in the fourth period. (Only VT was
measured in the final period.) In the third group of experiments (N 5 5),
100 mM hydrochlorothiazide (HCTZ) was added to the luminal perfusate
in the third period. The combined results from the three groups for JNa
and Pf in the control and AVP periods are shown in Figures 1A and 2A.
In all three groups, parameter measurements were made first in a control
period, followed by a period in which 200 pM AVP was added to the
bathing solution.
a Significantly different from control period, b significantly different
from preceding period, by ANOVA
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and VT in the control and AVP periods in this group were
not significantly different from the results in the DOC 1
low-salt group, and ouabain reversibly inhibited both pa-
rameters (Fig. 3). Upon the addition of AVP, Pf values,
while duplicating those observed in previous DOC 1
standard diet experiments [1–3, 17], were significantly
higher than seen in either the low-salt (P , 0.002) or the
DOC 1 low salt (P 5 0.02) groups.
DISCUSSION
We used volume depletion produced by a single injection
of furosemide followed by maintenance on a low Na1 diet
in order to examine the effects of physiologically relevant
plasma concentrations of aldosterone on Na1 transport
and its response to AVP in the rat CCD. Our objective in
using this regimen was to produce a significant elevation of
the plasma aldosterone concentration, without producing
severe volume depletion that could have had less specific
effects. Thus, the measured aldosterone concentration of
;0.7 nM for the seventeen rats used in the low-salt protocol
is significantly greater than that reported for rats on a
standard diet [11–13], but it is at the lower end of the
observed 0.6 to 4.3 nM range in rats on a low-Na1 or
Na1-free diet [11–13] and also in the range produced by
osmotic minipumps implanted in rats and delivering aldo-
sterone at rates calculated to mimic physiologically ele-
vated aldosterone secretion [18–20].
When CCD from our low-salt group were examined by in
vivo perfusion, we were surprised to find that JNa was not
significantly different from that observed in our previous
studies in CCD from rats without mineralocorticoid treat-
ment and maintained on a standard diet. From records kept
in our laboratory of previous experiments2, the average JNa
in CCD from rats on a standard diet with no mineralocor-
ticoid treatment was 38.1 6 3.3 pmol z min21 z mm21 (N 5
24) in the absence of AVP and 60.7 6 6.0 pmol z min21 z
mm21 (N 5 24) with 200 pM AVP. These values are not
significantly different from the respective averages of
22.1 6 12.4 and 48.6 6 16.0 pmol z min21 z mm21 obtained
in the present twelve experiments with CCD from low-salt
rats (Table 1). In the absence of AVP, VT in the low-salt
rats was not significantly different from our previous ob-
servations in CCD from either DOC-treated or untreated
2 We have maintained a database of all experiments we have conducted
in the rat CCD over the past nine years. Historical average parameter
values to which we make comparisons include only experiments in which
the age and treatment of the rats, the solutions for perfusion and
incubation, and all other conditions, were the same as in the present
experiments.
Fig. 3. Effect of 100 mM ouabain on lumen-to-bath 22Na1 flux (JNa) in
cortical collecting ducts (CCD) from rats implanted with a 2.5 mg
deoxycorticosterone (DOC) pellet and maintained on a standard diet.
Arginine vasopressin (AVP) was present in the bathing solution at 200 pM
in all but the first period. Results from individual experiments are shown
by the dashed lines, and the average for all experiments in a group by the
solid lines.
Table 2. Osmotic water permeability (Pf), transepithelial voltage (VT),
and lumen-to-bath 22Na1 flux (JNa) in cortical collecting ducts (CCD)
from rats treated with low-salt diet, furosemide and DOC
Experimental
period
Pf
mm/second
VT
mV
JNa
pmol z min21 z mm21
Control 293 6 28 24.4 6 0.8 39.0 6 4.2
AVP 530 6 73a 223.8 6 3.0a 103.4 6 12.7a
AVP & Epi 308 6 38ab 214.4 6 2.6ab 72.5 6 9.1ab
AVP, Epi & Yoh 482 6 57ab 219.0 6 2.5ab 88.1 6 12.0ab
CCD (N 5 11) were from rats that had been treated in vivo with DOC
and furosemide, and maintained on a low salt diet as described in the
Methods section. Parameter measurements were made first in a control
period, followed by a period in which 200 pM AVP was added to the
bathing solution.
a Significantly different from control period, b significantly different
from preceding period; by ANOVA.
Table 3. Osmotic water permeability (Pf), transepithelial voltage (VT),
and lumen-to-bath 22Na1 flux (JNa) in cortical collecting ducts (CCD)
from rats treated with deoxycorticosterone (DOC) and a 1% NaCl diet
Experimental
period
Pf
mm/second
VT
mV
JNa
pmol z min21 z mm21
Control 211 6 126 22.5 6 0.8 42.8 6 4.1
AVP 1003 6 224a 221.0 6 2.8a 114.2 6 11.4a
AVP & ouabain 1024 6 202a 211.0 6 2.5ab 51.6 6 9.7b
AVP 1331 6 296a 217.1 6 3.8ab 74.6 6 7.9ab
All CCD (N 5 7) were from rats that had been implanted with a DOC
pellet and maintained on a standard salt diet as described in the Methods
section. Parameter measurements were made first in a control period,
followed by 200 pM AVP added to the bathing solution. Ouabain (100 mM)
was added to the bathing solution in the third period, and removed in the
fourth period.
a Significantly different from control period, b significantly different
from preceding period, by ANOVA
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rats on a standard diet. On the other hand, the AVP-
dependent VT, which usually parallels JNa, averaged
217.3 6 2.2 mV. While this was significantly higher than
our historical average in AVP-treated CCD from rats on a
standard diet with no mineralocorticoid treatment (28.2 6
1.0 mV), it was not significantly different from our histor-
ical average of 221.8 6 0.7 mV (N 5 164) in AVP-treated
CCD from DOC-treated rats on a standard diet.
Another intriguing finding was that Pf rose much less
with AVP treatment than observed previously in CCD from
animals on a standard diet. In the low-salt rats Pf with AVP
averaged 418 6 208, which was significantly lower than our
historical averages of AVP-dependent Pf in CCD from
untreated rats (1009 6 99 mm/second, N 5 33, P , 0.01)
and DOC-treated rats (968 6 43, N 5 96, P , 0.01).
To summarize these comparisons: the JNa values in the
low-salt group with or without AVP were not significantly
different from values expected if the rats had been on a
standard diet with no mineralocorticoid treatment, but the
VT values after AVP treatment were at levels that we had
observed previously only in CCD from DOC-treated rats
on a standard 1% NaCl diet. The dissociation of JNa and VT
suggests that not only the active component of Na1 reab-
sorption is inhibited, but that there may also be a decreased
passive backflux through the paracellular pathway. An
increase in the paracellular resistance would explain the
persistence of a relatively high lumen-negative VT despite
diminished active transcellular transport. Structural alter-
ation of the CCD is also suggested by the fact that
AVP-dependent Pf in the low-salt group was significantly
lower than observed in CCD from rats on a standard diet
with or without DOC treatment.
We further examined CCD in the low-salt group by
attempting to inhibit the transport response to AVP using
epinephrine, ouabain, and HCTZ. We have previously
demonstrated that 100 nM epinephrine, acting through an
a2-adrenoceptor, almost completely inhibits Pf, JNa, and VT
in CCD from DOC-treated rats on a standard diet [17]. We
found the same effects in these experiments (Table 1)
although all of the parameters remained significantly
higher than control levels. Further addition of the a2-
adrenoceptor antagonist yohimbine reversed the effect of
the epinephrine. Although we previously demonstrated
that 100 mM ouabain reduced VT to nearly zero [21], its
effect on JNa and Pf had not previously been reported. As
expected, this Na,K-ATPase inhibitor reduced AVP-de-
pendent JNa and VT to values not significantly different
from the control, but had no effect on Pf. The effect on VT
was reversible; the reversibility of the effect on JNa was not
examined in this group (but see Table 3).
Although immunohistochemistry [22] and our previous
data [23] provide no evidence for the presence of the
thiazide-sensitive NaCl cotransporter in the CCD, we
tested the effect of HCTZ because of previous suggestions
that this cotransporter might be up-regulated by a low-salt
diet [19, 23]. However, we found no inhibition of JNa when
HCTZ was added to the luminal perfusate at 100 mM
(Table 1).
We next examined if the aldosterone levels produced by
the salt depletion might be limiting to the transport re-
sponse to AVP. In these experiments (Table 2) we used the
same low-salt protocol but also implanted the rats with a
2.5 mg pellet of DOC (the DOC 1 low salt group). JNa was
103 6 12 pmol z min21 z mm21 in the presence of AVP,
which is significantly lower than our historical average of
154.0 6 4.0 pmol z min21 z mm21 obtained in 161 experi-
ments with AVP-treated CCD from DOC-treated rats on a
standard diet. However, it should be noted that average
values of JNa in individual groups that comprise this histor-
ical average have been as low as 107 6 17 pmol z min21 z
mm21 (N 5 4) [3], which is not significantly different from
the value reported in Table 2. VT values in the DOC 1
low-salt group were not significantly different from histor-
ical averages in CCD from DOC-treated rats on a standard
diet, but the average AVP-dependent Pf (Table 2) was
again lower (P , 0.001) than the historical average Pf of
968 6 43 mm/s (N 5 96) observed in CCD from DOC-
treated rats on a standard diet.
To be sure that we could reproduce our previous results,
which have been used for comparison in the discussion
above, we examined CCD from DOC-treated rats that had
been maintained on the standard 1% NaCl diet. One of the
same experimenters who conducted the majority of the first
two series of experiments conducted these additional ex-
periments contemporaneously with the experiments re-
ported in Table 1. The rats were of the same size and age.
As shown in Table 3, JNa was significantly higher in this
group than in the low-salt group (Table 1; P , 0.001);
however, although the mean was greater than in the DOC
1 low-salt group (Table 2), the difference was not statisti-
cally significant.
The failure to observe a significant stimulation of JNa in
the low-salt protocol could be due to the fact that the
plasma aldosterone concentrations reached were much
lower than in other studies [4] in which a Na1-free diet or
significant volume depletion were used to elevate plasma
aldosterone. This explanation is reinforced by the fact that
administration of a pharmacological dose of DOC com-
bined with the low-salt diet (DOC 1 low-salt protocol)
resulted in a significantly higher JNa (Table 2). However,
administration of higher levels of mineralocorticoid might
still deliver an increased salt load to the CCD by a
“relative” DOC-escape despite the low salt diet. Also, in a
previous study from our laboratory in which the plasma
aldosterone concentration in rats on a standard salt diet
was elevated by implantation of a 1 mg aldosterone pellet,
there was significant stimulation of the AVP-dependent JNa
[3]. In those studies the average plasma aldosterone con-
centration was 0.51 6 0.07 nM, which is not significantly
different from the level in the present low-salt protocol, yet
Schafer and Chen: Low Na1 diet and AVP action in CCD 185
AVP increased JNa from 33.6 6 5.0 to 94.9 6 14.1
(unpublished averages from [3]), which is significantly
higher than observed in the present protocol (P , 0.01).
Furthermore, although the low-salt protocol did not elevate
JNa, it did increase AVP-dependent VT to the same levels as
observed in the DOC 1 low-salt and DOC 1 standard diet
protocols (Tables 2 and 3), and in previous studies in which
aldosterone was given in combination with a standard diet
[3]. Thus, the low-salt protocol had a definite effect on the
transport properties of the CCD, decreasing the AVP-
dependent Pf and markedly augmenting AVP-dependent
VT, despite its failure to augment the response of JNa to
AVP.
Consequently, we favor the view that the failure of the
low-salt protocol to significantly enhance the response of
JNa to AVP was due to a decrease in the in vivo NaCl
delivery to the CCD rather than to the lower level of
mineralocorticoid. Physiologic levels of aldosterone have
been shown to increase principal cell volume and basolat-
eral membrane surface area in the rat CCD, but the effect
was prevented when the animals were kept on a low-Na1
diet despite the fact that the plasma aldosterone concen-
tration was maintained in the high physiologic range by
osmotic minipump [20]. Both mineralocorticoid treatment
and increased distal Na1 load are correlated with increased
Na,K-ATPase activity in rat and rabbit CCD, but not if Na1
entry into the principal cells is prevented by amiloride or a
low luminal Na1 concentration [24–27].
More recent data indicate that increased salt delivery to
the distal nephron increases DNA synthesis in the cortical
distal tubule segments, which has been interpreted to
indicate increased cell proliferation [28]. However, as
shown by Barlet-Bas et al [24], the response to increased
Na1 delivery or intracellular concentration is not just
dependent on gene activation. In their studies, when Na1
entry into isolated rat CCD was increased by nystatin for
two to three hours, Na,K-ATPase activity increased mark-
edly, and this effect was prevented when Na1 was removed
from the bathing solution.
In our studies it would be expected that the initial
volume depletion produced by the single injection of
furosemide followed by the low Na1 diet would have
significantly reduced distal Na1 delivery. Although Ellison,
Vela´squez and Wright [7], using free flow micropuncture,
did not observe a statistically significant reduction of NaCl
delivery to the early distal tubule in rats on a salt restricted
diet, because of the variability in these measurements a
change of less than 25% could not have been discerned,
and they had not used furosemide to produce an initial
volume depletion as we had. However, in their studies
Ellison et al [7] did observe that volume flow to the early
distal tubule was significantly reduced by a low salt diet.
The reduced volume flow to the CCD in salt-depleted
rats may also be responsible for the reduced Pf in response
to AVP observed in both the low-salt and DOC 1 low-salt
protocols. [We have previously shown that osmotic water
flow and Na1 reabsorption are not directly coupled [1], that
is, the reflection coefficient of Na1 appears to be 1.0. This
lack of coupling is confirmed in the present experiments
(Tables 1 and 3) by the lack of any effect of ouabain on Pf
despite its inhibition of JNa.] As demonstrated previously
[29], an osmotic water permeability of 300 to 600 mm/
second is more than adequate to allow osmotic equilibra-
tion between the dilute luminal fluid in the distal nephron
and the isotonic cortex within the length of the CCD. Thus,
the very high water permeability of the AVP-treated rat
CCD on a standard diet could allow this segment to
operate as an isosmotic volume reabsorber to maximize salt
retention and negative free water clearance [29]. However,
this function of the CCD would not be compromised by a
lower Pf response to AVP in the low-salt rats because of
decreased fluid delivery and increased Na1 reabsorption in
the distal tubule [7].
If one also postulates that reduced Na1 delivery to the
CCD was responsible for the lack of a significant effect of
aldosterone on JNa, there must have been a concomitant
increase in paracellular resistance that would account for
the increase in VT. Alternatively, in the presence of de-
creased Na1 delivery AVP might still be acting to depolar-
ize the luminal membrane by increased Na1 channel
activity but transport would be limited by reduced Na,K-
ATPase activity. Given the results of studies showing that
Na,K-ATPase activity is stimulated by increased intracellu-
lar Na1 [26, 27], the latter explanation seems less plausible.
In summary, the low-salt experiments demonstrate that
maximal rates of active Na1 transport are achieved in the
rat CCD only when both mineralocorticoid and AVP are
present, and there is normal or elevated delivery of Na1 to
the CCD. The diminished JNa response to AVP in the
low-salt rats may reflect increased degradation and/or
decreased synthesis of the transporters involved, a “disuse
atrophy” so to speak, or it may be a function of the relative
plasma mineralocorticoid concentration achieved. These
observations also have important implications for the de-
sign of other studies in the CCD. Many investigators use a
low-salt diet to elevate the activity of Na1 channels to be
studied by patch clamping and other methods. Our results
suggest that Na1 channel activity would be maximized by in
vivo DOC administration in combination with a standard
salt diet.
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APPENDIX
Abbreviations used in this article are: AVP, arginine vasopressin; CCD,
cortical collecting duct; DOC, deoxycorticosterone; HCTZ, hydrochlo-
rothiazide; JNa, lumen-to-bath
22Na1 flux; Pf, osmotic water permeability;
VT, transepithelial voltage.
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